stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / ASTH

Astrana Health, Inc. (ASTH)

Healthcare · Medical Care Facilities · NasdaqCM

Price
$38.17
Market Cap
$1.89B
P/E Ratio
62.57
EPS
$0.61
Sector
Healthcare
52-Week High
$39.93
52-Week Low
$18.08
Dividend Yield

Astrana Health, Inc. revenue & earnings — last 10 fiscal years

Metric2017201720182019202020212022202320242025
Revenue$57.43M$356.36M$519.91M$560.62M$687.18M$773.91M$1.14B$1.39B$2.03B$3.18B
Gross profit$82.90M$158.78M$92.81M$147.97M$177.77M
Net income$-8.97M$25.80M$10.84M$14.12M$37.69M$68.92M$49.05M$60.72M$43.15M$22.49M
Net margin-15.6%7.2%2.1%2.5%5.5%8.9%4.3%4.4%2.1%0.7%

Source: Astrana Health, Inc. SEC filings (10-K). 17 years of history available in the interactive view.

Explore 17 years of Astrana Health, Inc. financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track ASTH in your portfolio →

About Astrana Health, Inc.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Astrana Health, Inc. — frequently asked questions

What is Astrana Health, Inc.'s revenue?

Astrana Health, Inc. (ASTH) reported revenue of $3.18B for fiscal year 2025, up 56.4% from the prior year, according to its SEC filings.

Is Astrana Health, Inc. profitable?

Yes. ASTH earned net income of $22.49M in fiscal 2025, a net margin of 0.7%.

What is ASTH's P/E ratio?

Astrana Health, Inc. trades at a price-to-earnings ratio of about 62.6 based on the latest data in our nightly-refreshed cache.

How fast is Astrana Health, Inc. growing?

ASTH's revenue grew at roughly 35.9% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

Where does this data come from?

All figures are computed from Astrana Health, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 500+ companies → · Screen them by fundamentals →